Objective. To estimate the early prevalence of various electrocardiographic (EKG) abnormalities in patients with
INTRODUCTION
detection of prolongation of the heart rate corrected QT (QTc) interval and increased QT dispersion (QTd), defined as the difference between maximal and minimal QT intervals from different EKG leads. Because these EKG abnormalities may confer an increased risk of ventricular arrhythmias and sudden cardiac death (1, 2) , early identification may have prognostic value.
Some evidence suggests that anti-Ro/SSA antibodies, strongly associated with congenital heart block in neonatal lupus, may also lead to QTc prolongation among adults with systemic autoimmune rheumatic diseases (3, 4) . In addition, the specific anti-Ro/SSA subtype (against 52-kd or 60-kd subunit) as well as its level may be important factors in determining the effect of this autoantibody on the cardiomyocytes, both in the fetus and in adults (5, 6) . Previous studies that attempted to examine the relationship between anti-Ro/SSA antibodies and QTc prolongation in systemic autoimmune rheumatic diseases were single center and limited by a relatively small number of participants. Therefore, the literature is scant and conflicting, and the effect of anti-Ro/SSA in adults with SLE remains unclear (7, 8) .
Given this background, we evaluated the prevalence of various EKG abnormalities in a large international inception cohort of patients with SLE and assessed for possible associations between repolarization abnormalities (QTc prolongation and increased QTd) and various clinical and laboratory variables, including the anti-Ro/SSA level and specificity (52 and 60 kd).
MATERIALS AND METHODS

Study population. The Systemic Lupus International
Collaborating Clinics (SLICC) is a group of SLE experts who have developed an international registry of newly diagnosed SLE patients, the SLICC Prospective Inception Cohort. The present analysis includes adult patients from 19 centers in 8 different countries participating in this inception cohort. Patients were enrolled within 15 months of their date of diagnosis based on American College of Rheumatology (ACR) classification criteria (9 • Although the pathogenic role of anti-Ro/SSA in the fetal heart is well recognized, its effect on the adult heart is uncertain, and previous studies that attempted to examine the relationship between anti-Ro/SSA antibodies and repolarization abnormalities in SLE patients were single center and limited by a relatively small number of participants. We did not demonstrate an association between repolarization abnormalities and the antiRo/SSA specificities or level in our large population of 779 SLE patients. 
Study variables.
Clinical and laboratory variables from the baseline or the first followup visit were studied as potential factors associated with EKG abnormalities, and included age, sex, disease duration, SLEDAI-2K, SDI, arterial hypertension (Ͼ140/90 mm Hg recorded at visit), body mass index, current smoking status, alcohol consumption, history of CAD (including myocardial infarction, percutaneous coronary intervention, and coronary bypass surgery), valvular heart disease, and cardiomyopathy. Relevant medication use that could impact cardiovascular status included nonsteroidal antiinflammatory drugs, antimalarials, antihypertensive agents (diuretics, adrenergic inhibitors, beta-blockers, central alpha agonists, calcium-channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers), nitrates, lipid-lowering agents, steroids, warfarin, heparin, acetylsalicylic acid, contraceptive pills, hormone replacement, thyroid replacement, and immunosuppressive drugs, including azathioprine, mycophenolate mofetil, methotrexate, and cyclophosphamide. The following laboratory tests were performed in a central laboratory: calcium, albumin, potassium, and magnesium levels; antidouble-stranded DNA; and anti-extractable nuclear antigen (anti-ENA) profile (anti-Ro/SSA subspecificities [52 kd and 60 kd], anti-La/SSB, anti-Sm, and anti-RNP). The measurement of autoantibodies was performed by addressable laser bead immunoassay (BioPlex 2200; Bio-Rad), which permits the simultaneous detection of all autoantibodies of interest. Patients were classified as positive or negative (cutoff value of Ն1.0 autoantibody index as positivity) and the titer of the positivity was measured. Lipid profile (with hyperlipidemia defined as greater than the upper limit of the testing laboratory), glucose (with diabetes mellitus defined as fasting blood glucose Ͼ7 mmoles/liter), and highsensitivity C-reactive protein level were measured at local laboratories.
EKG.
Depending on the quality of the printout, the 12-lead EKG from either the baseline or the first followup visit (25 mm/second paper speed and 10 mm/mV amplitude) was initially manually interpreted by 3 board-certified cardiologists blinded to any clinical information at an independent central core laboratory. Rhythm, conduction diseases, ST-T changes, chamber hypertrophy, QT interval duration, and QTd were assessed. The QT intervals were assessed without magnification and recorded in milliseconds approximated to the nearest 10 msec. The QT interval was defined as the time between the first deflection from the isoelectric PR interval and the visual return of the T wave to the T-P segment. Measurements immediately following atrial or ventricular premature contractions were avoided. Computer-assisted reading was also performed and interpretations were performed according to International Conference on Harmonisation (ICH) guidelines (12) . For those lacking computer-generated QTc, the median raw QT was used to derive the Bazett QTc interval (13) . QTd was defined as the difference between maximal and minimal QT intervals and required a minimum of 8 interpretable leads, as previously described (14) . Proportions of patients with QTc prolongation crossing categorical regulatory thresholds according to the ICH guidance document (440 msec, 450 msec, 460 msec, 480 msec, and 500 msec) (12) and increased QTd (defined as Ͼ40 msec) were also assessed.
Statistical analyses.
Descriptive statistics are shown using means, medians, SDs, interquartile ranges, and proportions, as appropriate. We first estimated the effects of various demographic, clinical, and laboratory factors on the prolongation of the QTc interval using univariate analyses. We also fit multivariate logistic and linear models, which included continuous variables for age, SLE disease duration, SLEDAI-2K, SDI, and corrected calcium, potassium, and magnesium levels, as well as dichotomous variables for sex, anti-ENA, CAD risk factors, and drug exposure. We investigated confounding by comparing odds ratios (ORs) for each main variable of interest as possible confounders exited or entered the model. Analyses were performed using SAS software, version 9.2. The study was approved by the institutional ethics boards of the involved clinics and written consent was obtained from each subject according to the Declaration of Helsinki.
RESULTS
Characteristics of the patients. Seven hundred seventynine subjects participated in this study. Baseline characteristics of the patients are shown in Table 1 . The majority (88.4%) were women, 50.7% were white, 22.9% were Asian, 13.1% were African American, and 9.3% were Hispanic. At assessment, the mean Ϯ SD age was 35.2 Ϯ 13.8 years and the mean Ϯ SD lupus disease duration was short, at 10.5 Ϯ 14.5 months, as would be expected with an inception cohort. At the time of the assessment, 47.3% had positive anti-Ro/SSA (52 and/or 60 kd), among which 30.2% were anti-Ro/SSA 52 kd positive, 44.2% were antiRo/SSA 60 kd positive, and 27.0% were both anti-Ro/SSA 52 and 60 kd positive. Cardiovascular history and risk factors among the study participants are detailed in Table 2 . Thirty-one percent of the patients had hypertension and 14.8% were current smokers. Known CAD and structural heart disease were relatively uncommon in the cohort.
EKG abnormalities. The proportions of patients with various EKG abnormalities are shown in Table 3 . Premature atrial and ventricular complexes occurred in 1.15% and 1.40% of the patients, respectively. Atrial fibrillation and other supraventricular arrhythmias were less frequent (0.13%). Prominent QRS voltages, suggestive of left ventricular hypertrophy, were found in 5.40% of this population of young patients. Among the patients with ventricular conduction disturbances, incomplete bundle branch block was the most frequent abnormality. Nonspecific Clinical and laboratory associations. Table 4 compares the rate of repolarization abnormalities among the various Ro/SSA subgroups (Ro/SSA negative, Ro/SSA 52 kd positive, Ro/SSA 60 kd positive, Ro/SSA 52 kd and/or 60 kd positive, and both Ro/SSA 52 kd and 60 kd positive). Although the mean QTc and the proportion of patients with QTc Ն440 msec were slightly higher in Ro/SSApositive groups compared to the Ro/SSA-negative group, wide confidence intervals (CIs) preclude definitive conclusions.
In univariate and multivariate analyses, anti-Ro/SSA antibodies, for any subtype, were not associated with QTc prolongation (Table 5) or increase in QTd (Table 6) . Similarly, there was no effect of anti-Ro/SSA level on these parameters (data not shown).
Other variables. In univariate analysis, the following variables were associated with QTc prolongation and showed a stronger association for higher QTc Contribution of the variables to multivariate models has been assessed and, with the exception of antihypertensive drugs and increasing age, we were unable to determine if any clinical or laboratory factors were associated with prolonged QTc or QTd (Table 5 ). In particular, although the CIs were large, neither the level of electrolytes (potassium, magnesium, or corrected calcium) nor the presence of any antibodies was found to impact QTc interval duration or QTd.
DISCUSSION
Our study is by far the largest to date evaluating EKG abnormalities and more specifically, the relationship between anti-Ro/SSA and repolarization abnormalities in SLE patients. Although many patients in our cohort were young (mean age 35.2 years) and had a short disease duration (mean 10.5 months), a considerable number of patients in the SLICC cohort already demonstrated evidence of cardiac abnormalities by EKG. In data from a healthy population of women ages 25-44 years (15) , the mean prevalence of most EKG abnormalities has been reported to be relatively low: 0.1% atrioventricular block, 0.2% bundle branch block, 0.04% atrial fibrillation or flutter, and 0.1% QRS voltage criteria indicative of left ventricular hypertrophy. However, our cohort was not restricted to women and also included subjects older than the age range 25-44 years. However, analyzing the sample of women ages 25-44 years from our cohort, the mean prevalence of most EKG abnormalities remains high, at 0.85% atrioventricular block, 4.79% bundle branch block, and 4.2% left ventricular hypertrophy, although atrial fibrillation or flutter was not seen in this subpopulation. Abnormalities such as conduction defects may represent sequelae of past or active lupus myocarditis (16) and could also be related to the high rate of CAD risk factors such as hypertension in our patients, although SLE itself carries an independent risk for CAD even after adjustment for traditional Framingham risk factors (17) .
Although a substantial proportion of patients in our cohort manifested repolarization abnormalities such as prolonged QTc (15.3%) and increased QTd (38.1%), se- * Values are the odds ratio (95% confidence interval) from multivariate analysis, except for the first column, where they are the regression coefficient (95% confidence interval) from linear regression models. Variables not appearing in the table were removed from the final model because they were not predictive of the outcome nor they were confounders. The small number of patients (n ϭ 2) with QTc Ն500 msec precludes multivariate analysis at this threshold. QTc ϭ corrected QT interval. † Significant. 132 Bourré-Tessier et al vere abnormalities were rare (Ͻ1% with QTc Ն550 msec). QTc prolongation is an independent risk factor for the development of complex ventricular arrhythmias, and rarely, sudden death (1,2). Increased QTd is another indicator of myocardial electrical instability that has been associated with arrhythmias and cardiac death (18) . In general medical populations, QTd is an independent predictor of cardiovascular mortality (hazard ratio 1.28 [95% CI 1.01, 1.60] per each 10-msec increase in QTd) (19) . In patients with rheumatic diseases, a 50-msec increase in the QTc interval has been associated with a doubling of the relative hazard for all-cause mortality, and some authors have suggested a connection between disease activity and arrhythmogenesis (20) . Important associations of repolarization abnormalities in our study included age and antihypertensive therapy, which is not surprising, since both have been associated with prolonged QTc (21) (22) (23) . Wide CIs precluded definitive conclusions for other clinical and laboratory variables in our study, although numerical increases in the QTc interval were observed with anti-Ro/ SSA antibody positivity. Because of their recognized arrhythmogenic effect on the fetal heart, anti-Ro/SSA antibodies have been examined as potential determinants of QTc prolongation in adults with connective tissue diseases (CTDs). The pathogenic role of anti-Ro/SSA and anti-La/SSB antibodies in neonatal lupus is universally accepted, although the exact mechanisms of injury have not been completely clarified. In vivo and in vitro evidence supports a pathologic cascade involving cardiomyocytes apoptosis, binding of maternal antibodies, inflammation, and subsequent replacement of inflamed tissue with fibrosis (24 -27) . Inhibition of L-type and T-type calcium channels also seems to play an important role (28) . However, these mechanisms, which generally lead to irreversible conduction abnormalities, would not explain the reversible changes that are hypothesized to occur in adult patients. Indeed, some evidence, such as the concomitant disappearance of QTc abnormalities and acquired maternal autoantibodies during the first year of life (29) , suggests that anti-Ro/SSA antibodies may cause a direct reversible arrythmogenic effect on ventricular repolarization. However, the pathophysiology underlying QTc prolongation seems to be different from the one involved in neonatal cardiac block, and evidence suggests an inhibitory activity of these autoantibodies on the potassium currents, resulting in an impairment of the ventricular repolarization (30) .
In patients with various types of CTD, Lazzerini and colleagues showed statistically significant prolongation of the QTc interval in anti-Ro/SSA-positive adults compared to anti-Ro/SSA-negative adults (4, 5, 31) . Our previous single-center study, performed on a large group of SLE patients with a mean age of 44.8 years and a mean disease duration of 12.9 years, also demonstrated an association between anti-Ro/SSA antibodies and QTc interval prolongation (3). In the current study, although the proportion of patients with prolonged QTc was slightly higher in antiRo/SSA-positive groups compared to the anti-Ro/SSAnegative group, CIs were wide and included both important effects and the null value, and therefore were inconclusive. In contrast to a recent study reporting that QTc prolongation was strictly dependent on the antiRo/SSA 52-kd level in a population of 49 subjects with various CTDs (5), we did not demonstrate an association between the anti-Ro/SSA specificities or level in our population of 779 SLE patients. Our results are, however, in accordance with previous studies involving a majority of SLE patients who did not demonstrate differences in QTc duration or QTd between anti-Ro/SSA-positive and antiRo/SSA-negative patients (7, 8, 32) . It has been proposed previously that SLE patients may have a peculiar resistance to the hypothesized electrophysiologic effects of anti-Ro/SSA antibodies as compared with patients with other CTDs (33) . It may also be possible that our lack of ability to show an effect was because of the young age and short disease duration of the patients in our cohort.
Numerous centers around the world participated in our study, and some factors that may impact EKG acquisition (e.g., type of EKG equipment, body position, and fasting state of the participants) were not standardized. However, both EKG interpretation and antibody testing were performed with highly robust methods in a single center. Because no association was found between antiphospholipid antibodies and EKG abnormalities in previous studies, we did not test for these autoantibodies (3). Other potential limitations of the present study include the use of resting 12-lead EKGs rather than 24-hour EKG monitoring (Holter), which can measure diurnal variations of EKG intervals. However, it has been previously shown that QTc prolongation, when present, persists for most of the 24-hour observation period (31) . For those lacking computergenerated QTc (21.8% of the participants), the median raw QT was used to derive the Bazett QTc interval, which overcorrects at high heart rates and undercorrects at low heart rates (13) . This could contribute to the null effect of our study. Since the threshold at which QTc duration should be considered abnormal also has been a matter of debate for many years (34, 35) , we used different cutoffs in our analysis, from 440 msec to 500 msec.
In conclusion, we demonstrated a relatively high prevalence of EKG abnormalities, including repolarization abnormalities, in this inception cohort, although severe abnormalities were rare.
